Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The rostral ventromedial medulla (RVM) is thought to play a crucial role in the antinociceptive actions of cannabinoids. This study examined the actions of the cannabinoid receptor agonist, WIN55,212‐2, on membrane properties and GABAergic synaptic transmission in RVM neurons using whole cell patch clamp recordings in brain slices. WIN55,212‐2 (3 μ M ) had no effect on membrane K + conductance of primary or secondary RVM neurons. Primary neurons responded to the κ‐opioid receptor agonist U69,593 (300 n M –1 μ M ). Secondary neurons responded to the μ,δ‐opioid receptor agonist met‐enkephalin (10 μ M ). WIN55,212‐2 reduced the amplitude of electrically evoked (GABAergic) inhibitory postsynaptic currents (IPSCs) in all neurons (58%, pEC 50 =6.2±0.1). The inhibition was reversed by the CB 1 receptor selective antagonist, SR141716 (3 μ M ). WIN55,212‐2 also produced relative facilitation of the second IPSC to paired evoked IPSCs. WIN55,212‐2 and met‐enkephalin reduced the rate of spontaneous miniature IPSCs in all cells (44 and 53%), but had no effect on their amplitude distributions or kinetics. These results suggest that the antinociceptive actions of cannabinoids within RVM are primarily due to presynaptic inhibition of GABAergic neurotransmission. The neuronal substrates of cannabinoid actions in RVM therefore differ from those of opioids, which have both pre‐ and postsynaptic inhibitory actions. British Journal of Pharmacology (1999) 127 , 935–940; doi: 10.1038/sj.bjp.0702636
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 3×
“…may also be due to overexpression of cannabinoid receptors in transfected cells, variations in receptor reserve between di erent brain regions particularly given the relatively low levels of cannabinoid binding sites in the RVM (Herkenham et al., 1991), and di erences receptor/e ector coupling.”
BackgroundMethodLocalization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 2×
“The absence of postsynaptic actions of cannabinoid agonists on RVM neurons is consistent with the relatively low density of cannabinoid receptor binding sites and CB1 mRNA in the region (Herkenham et al., 1991; Matsuda et al., 1993).”
BackgroundMethodCannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544 · cited 1×
“However, the potency of WIN55,212 was much greater in other studies using hippocampal cultures (Shen et al., 1996; Twitchell et al., 1997) and transfected cells (Mackie et al., 1995).”
BackgroundAn analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · cited 4×
“The rostral ventromedial medulla (RVM) is thought to be critical for the supraspinal antinociceptive actions of both opioids and cannabinoids (Fields et al., 1991; Martin et al., 1998; Meng et al., 1998).”
BackgroundInfluentialThe Enhancement of Morphine Antinociception in Mice by Î9-Tetrahydrocannabinol
Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146 · cited 1×
“Cannabinoid receptor agonists produce antinociception and synergistically enhance the analgesic actions of opioids after either systemic or central administration (Smith et al., 1998; see Howlett, 1995 for review).”
Background
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Central nervous system mechanisms of pain modulation
Fields, H. L., Basbaum, A. I., & Heinricher, M. M. (2006) · Wall and Melzack's Textbook of Pain · doi:10.1016/b0-443-07287-6/50012-6 · Cited by 757
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
E. Alger, B. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 598
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
The neurobiology and evolution of cannabinoid signalling
Elphick, M. R., & Egertova, M. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 417
Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus
Hoffman, A. F., & Lupica, C. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02470.2000 · Cited by 399
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia
Lau, B. K., & Vaughan, C. W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.010 · Cited by 297
Self-citationManzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287
“Two have been cloned, type 1 (CB 1 ) and type 2 (CB 2 ) cannabinoid receptors [100] [108], while the other two, WIN and abnormal-cannabidiol (abn-CBD) receptors (the latter also known as anandamide receptor), have been characterised pharmacologically [8] [31] [51] [71] [107].”
InfluentialEffects of Cannabinoids on Neurotransmission
Szabo, B., & Schlicker, E. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_11 · Cited by 252
Potential Analgesic Mechanisms of Acetaminophen
Smith, H. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/269 · Cited by 245
Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., & Eschalier, A. (2008) · Pain · doi:10.1016/j.pain.2008.03.030 · Cited by 223
“Notably, the stimulation of CB1 receptors in PAG and RVM reduced GABA release from the presynaptic boutons of local interneurons which can reduce the GABAergic negative influence on the inhibitory descending pathways [49,50].”
BackgroundWei, F., Dubner, R., Zou, S., Ren, K., Bai, G., Wei, D., & Guo, W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5389-09.2010 · Cited by 209
“Wholecell patch recording has further revealed that KOR agonists produced an outward current in a subpopulation of RVM neurons (Pan et al., 1997; Vaughan et al., 1999; Ackley et al., 2001), which purportedly contain 5-HT (Pan et al.”
BackgroundDiana, M. A., Levenes, C., Mackie, K., & Marty, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00200.2002 · Cited by 199
“…has been shown to inhibit GABA release in many different areas of the CNS (for example, rostral ventromedial medulla and periaqueductal gray: Vaughan et al., 1999, 2000; hippocampus: Katona et al., 1999; Hajos et al., 2000; Hoffmann and Lupica, 2000; cerebellum: Takahashi and Linden, 2000;…”
BackgroundWalker, J. M., & Huang, S. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00252-8 · Cited by 176
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Liang, Y., Huang, C., Hsu, K., & Takahashi, T. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.056986 · Cited by 42
“…Yung, 1999), the nucleus accumbens (Robbe et al. 2001), the dorsal striatum (Huang et al. 2001; Gerdeman & Lovinger, 2001), the periaqueductal grey (Vaughan et al. 1999), the cerebellum (Lèvènés et al. 1998), the prefrontal cortex (Auclair et al. 2000), and the spinal cord dorsal horn (Morisset…”
Background
Metadata
- Authors
- Vaughan, C. W., McGregor, I. S., & Christie, M. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 127
- Issue
- 4
- Pages
- 935-940
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2030864168
- Cited by
- 137
- References
- 5
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.